CN Stock MarketDetailed Quotes

600055 Beijing Wandong Medical Technology

Watchlist
  • 13.78
  • +0.56+4.24%
Market Closed Sep 27 15:00 CST
9.69BMarket Cap49.04P/E (TTM)

Beijing Wandong Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
17.79%700.09M
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
-12.25%210.6M
Operating revenue
17.79%700.09M
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
-12.25%210.6M
Other operating revenue
16.04%28.36M
----
39.65%75.73M
----
2.34%24.44M
----
0.14%54.23M
----
11.95%23.88M
----
Total operating cost
15.64%611.62M
19.44%277.82M
16.23%1.11B
32.14%825.71M
32.67%528.91M
22.00%232.59M
-3.55%951.61M
-8.81%624.9M
-5.72%398.68M
0.43%190.66M
Operating cost
20.17%423.3M
26.08%192.94M
13.72%712.58M
32.60%540.76M
38.32%352.26M
38.87%153.03M
0.03%626.61M
-2.12%407.82M
-0.38%254.67M
-5.45%110.2M
Operating tax surcharges
5.81%6.21M
-50.66%761.83K
-21.07%11.86M
-7.77%7.35M
-0.67%5.87M
1.73%1.54M
0.46%15.02M
-6.81%7.97M
-6.37%5.91M
-16.31%1.52M
Operating expense
-5.83%99.98M
3.98%49.63M
27.98%223.26M
38.96%163.75M
34.52%106.16M
21.33%47.73M
-5.93%174.46M
-17.14%117.83M
-10.69%78.92M
8.78%39.34M
Administration expense
-5.99%38.12M
-3.67%17.95M
19.32%80.77M
14.37%58.29M
17.01%40.55M
-1.51%18.63M
-4.05%67.69M
-0.10%50.96M
-7.76%34.65M
4.54%18.92M
Financial expense
13.66%-34.97M
-8.52%-18.66M
-14.42%-80.01M
-24.32%-54.21M
-63.20%-40.5M
-311.88%-17.19M
-214.34%-69.92M
-653.32%-43.61M
-682.87%-24.82M
-108.04%-4.17M
-Interest expense (Financial expense)
-28.27%282.24K
----
-14.40%1.25M
-1.15%568.85K
13.30%393.47K
--98.14K
-2.61%1.47M
--575.49K
--347.27K
----
-Interest Income (Financial expense)
5.31%-34.31M
-0.16%-18.72M
-31.42%-81.13M
-54.45%-50.91M
-87.87%-36.23M
-304.51%-18.69M
-136.48%-61.73M
-409.60%-32.96M
-384.52%-19.28M
-152.20%-4.62M
Research and development
22.33%78.99M
21.98%35.19M
14.38%157.56M
30.82%109.77M
30.86%64.57M
16.04%28.85M
23.57%137.76M
15.47%83.91M
29.26%49.34M
29.24%24.86M
Credit Impairment Loss
-18.27%2.38M
----
67.58%-7.45M
143.95%2.91M
143.95%2.91M
5,571.88%85.24K
-33.42%-22.99M
-50.79%-6.62M
-51.18%-6.62M
---1.56K
Asset Impairment Loss
-421.39%-4.87K
----
55.09%-2.11M
48.53%1.52K
48.53%1.52K
----
31.62%-4.7M
-99.86%1.02K
-99.60%1.02K
----
Other net revenue
-53.06%13.42M
-46.93%6.88M
260.20%82.68M
84.90%46.2M
117.59%28.58M
23.04%12.97M
-41.38%22.95M
-31.06%24.99M
-54.57%13.14M
21.07%10.54M
Fair value change income
1,358.72%781.48K
----
1,096.13%34.59M
100.88%53.57K
101.02%53.57K
101.17%53.57K
-61.98%-3.47M
-1,677.57%-6.11M
-1,421.32%-5.23M
---4.56M
Invest income
-12.48%1.48M
-77.01%131.43K
-61.25%8.29M
-63.30%5.24M
-82.14%1.69M
-92.13%571.64K
1.93%21.39M
12.92%14.29M
-18.15%9.48M
156.38%7.27M
-Including: Investment income associates
76.57%-111.34K
111.03%28.28K
-951.31%-2.05M
-518.24%-925.01K
-400.49%-475.13K
-535.08%-256.5K
-149.64%-195.21K
-66.50%221.17K
-70.67%158.12K
-82.04%58.96K
Asset deal income
-57.79%24.51K
----
83.13%-301.52K
100.47%1.12K
126.55%58.07K
113.74%38.52K
-648.78%-1.79M
-53.80%-241.15K
-50.67%-218.72K
-135.92%-280.35K
Other revenue
-63.32%8.75M
-44.75%6.75M
43.92%49.66M
60.52%37.99M
51.84%23.87M
50.59%12.22M
-22.72%34.51M
-14.65%23.67M
-28.35%15.72M
35.48%8.11M
Operating profit
8.38%101.88M
5.93%37.56M
10.79%213.33M
10.20%146.28M
32.44%94M
16.32%35.46M
-7.76%192.55M
-12.47%132.74M
-29.63%70.98M
-48.21%30.48M
Add:Non operating Income
13,413.89%1.46M
----
4,150.52%866.89K
18,925.67%11.42K
17,925.67%10.82K
--3.46K
883.19%20.39K
-97.11%60
-97.11%60
----
Less:Non operating expense
3,067.60%941.89K
85.22%21.41K
564.09%860.99K
--523.48K
--29.74K
--11.56K
-91.47%129.65K
----
----
----
Total profit
8.95%102.4M
5.89%37.54M
10.86%213.33M
9.81%145.77M
32.41%93.99M
16.30%35.45M
-7.14%192.44M
-12.35%132.74M
-29.49%70.98M
-48.21%30.48M
Less:Income tax cost
3.43%16.9M
-41.74%3.37M
10.41%22.52M
-18.70%23.94M
43.10%16.34M
13.28%5.78M
-24.33%20.4M
-7.64%29.45M
-36.84%11.42M
-49.53%5.1M
Net profit
10.12%85.5M
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
Net profit from continuing operation
10.12%85.5M
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
Less:Minority Profit
-52.78%756.27K
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
408.07%750.13K
Net profit of parent company owners
11.44%84.74M
9.26%33.26M
7.51%188.54M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.27%175.37M
-14.29%103.13M
-28.72%59.31M
-49.73%24.63M
Earning per share
Basic earning per share
9.09%0.12
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
-49.45%0.046
Diluted earning per share
9.09%0.12
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
-49.45%0.046
Other composite income
-100.25%-1.35M
-48.41%-674.9K
Other composite income of parent company owners
----
----
-100.25%-1.35M
----
----
----
-48.41%-674.9K
----
----
----
Total composite income
10.12%85.5M
15.16%34.17M
10.56%189.46M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.70%171.36M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
Total composite income of parent company owners
11.44%84.74M
9.26%33.26M
7.15%187.19M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.40%174.69M
-14.29%103.13M
-28.72%59.31M
-49.73%24.63M
Total composite income of minority owners
-52.78%756.27K
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
408.07%750.13K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 17.79%700.09M20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M-12.25%210.6M
Operating revenue 17.79%700.09M20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M-12.25%210.6M
Other operating revenue 16.04%28.36M----39.65%75.73M----2.34%24.44M----0.14%54.23M----11.95%23.88M----
Total operating cost 15.64%611.62M19.44%277.82M16.23%1.11B32.14%825.71M32.67%528.91M22.00%232.59M-3.55%951.61M-8.81%624.9M-5.72%398.68M0.43%190.66M
Operating cost 20.17%423.3M26.08%192.94M13.72%712.58M32.60%540.76M38.32%352.26M38.87%153.03M0.03%626.61M-2.12%407.82M-0.38%254.67M-5.45%110.2M
Operating tax surcharges 5.81%6.21M-50.66%761.83K-21.07%11.86M-7.77%7.35M-0.67%5.87M1.73%1.54M0.46%15.02M-6.81%7.97M-6.37%5.91M-16.31%1.52M
Operating expense -5.83%99.98M3.98%49.63M27.98%223.26M38.96%163.75M34.52%106.16M21.33%47.73M-5.93%174.46M-17.14%117.83M-10.69%78.92M8.78%39.34M
Administration expense -5.99%38.12M-3.67%17.95M19.32%80.77M14.37%58.29M17.01%40.55M-1.51%18.63M-4.05%67.69M-0.10%50.96M-7.76%34.65M4.54%18.92M
Financial expense 13.66%-34.97M-8.52%-18.66M-14.42%-80.01M-24.32%-54.21M-63.20%-40.5M-311.88%-17.19M-214.34%-69.92M-653.32%-43.61M-682.87%-24.82M-108.04%-4.17M
-Interest expense (Financial expense) -28.27%282.24K-----14.40%1.25M-1.15%568.85K13.30%393.47K--98.14K-2.61%1.47M--575.49K--347.27K----
-Interest Income (Financial expense) 5.31%-34.31M-0.16%-18.72M-31.42%-81.13M-54.45%-50.91M-87.87%-36.23M-304.51%-18.69M-136.48%-61.73M-409.60%-32.96M-384.52%-19.28M-152.20%-4.62M
Research and development 22.33%78.99M21.98%35.19M14.38%157.56M30.82%109.77M30.86%64.57M16.04%28.85M23.57%137.76M15.47%83.91M29.26%49.34M29.24%24.86M
Credit Impairment Loss -18.27%2.38M----67.58%-7.45M143.95%2.91M143.95%2.91M5,571.88%85.24K-33.42%-22.99M-50.79%-6.62M-51.18%-6.62M---1.56K
Asset Impairment Loss -421.39%-4.87K----55.09%-2.11M48.53%1.52K48.53%1.52K----31.62%-4.7M-99.86%1.02K-99.60%1.02K----
Other net revenue -53.06%13.42M-46.93%6.88M260.20%82.68M84.90%46.2M117.59%28.58M23.04%12.97M-41.38%22.95M-31.06%24.99M-54.57%13.14M21.07%10.54M
Fair value change income 1,358.72%781.48K----1,096.13%34.59M100.88%53.57K101.02%53.57K101.17%53.57K-61.98%-3.47M-1,677.57%-6.11M-1,421.32%-5.23M---4.56M
Invest income -12.48%1.48M-77.01%131.43K-61.25%8.29M-63.30%5.24M-82.14%1.69M-92.13%571.64K1.93%21.39M12.92%14.29M-18.15%9.48M156.38%7.27M
-Including: Investment income associates 76.57%-111.34K111.03%28.28K-951.31%-2.05M-518.24%-925.01K-400.49%-475.13K-535.08%-256.5K-149.64%-195.21K-66.50%221.17K-70.67%158.12K-82.04%58.96K
Asset deal income -57.79%24.51K----83.13%-301.52K100.47%1.12K126.55%58.07K113.74%38.52K-648.78%-1.79M-53.80%-241.15K-50.67%-218.72K-135.92%-280.35K
Other revenue -63.32%8.75M-44.75%6.75M43.92%49.66M60.52%37.99M51.84%23.87M50.59%12.22M-22.72%34.51M-14.65%23.67M-28.35%15.72M35.48%8.11M
Operating profit 8.38%101.88M5.93%37.56M10.79%213.33M10.20%146.28M32.44%94M16.32%35.46M-7.76%192.55M-12.47%132.74M-29.63%70.98M-48.21%30.48M
Add:Non operating Income 13,413.89%1.46M----4,150.52%866.89K18,925.67%11.42K17,925.67%10.82K--3.46K883.19%20.39K-97.11%60-97.11%60----
Less:Non operating expense 3,067.60%941.89K85.22%21.41K564.09%860.99K--523.48K--29.74K--11.56K-91.47%129.65K------------
Total profit 8.95%102.4M5.89%37.54M10.86%213.33M9.81%145.77M32.41%93.99M16.30%35.45M-7.14%192.44M-12.35%132.74M-29.49%70.98M-48.21%30.48M
Less:Income tax cost 3.43%16.9M-41.74%3.37M10.41%22.52M-18.70%23.94M43.10%16.34M13.28%5.78M-24.33%20.4M-7.64%29.45M-36.84%11.42M-49.53%5.1M
Net profit 10.12%85.5M15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M-47.94%25.38M
Net profit from continuing operation 10.12%85.5M15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M-47.94%25.38M
Less:Minority Profit -52.78%756.27K219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K408.07%750.13K
Net profit of parent company owners 11.44%84.74M9.26%33.26M7.51%188.54M16.54%120.18M28.21%76.04M23.57%30.44M-4.27%175.37M-14.29%103.13M-28.72%59.31M-49.73%24.63M
Earning per share
Basic earning per share 9.09%0.129.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1-49.45%0.046
Diluted earning per share 9.09%0.129.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1-49.45%0.046
Other composite income -100.25%-1.35M-48.41%-674.9K
Other composite income of parent company owners ---------100.25%-1.35M-------------48.41%-674.9K------------
Total composite income 10.12%85.5M15.16%34.17M10.56%189.46M17.94%121.82M30.36%77.64M16.90%29.67M-4.70%171.36M-13.61%103.29M-27.88%59.56M-47.94%25.38M
Total composite income of parent company owners 11.44%84.74M9.26%33.26M7.15%187.19M16.54%120.18M28.21%76.04M23.57%30.44M-4.40%174.69M-14.29%103.13M-28.72%59.31M-49.73%24.63M
Total composite income of minority owners -52.78%756.27K219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K408.07%750.13K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data